Moclobemide techin gallate SCH 51344-induced reversal of RAS-transformation

SCH 51344-induced reversal of RAS-transformation is accompanied by the specific inhibition of the RAS and RAC-dependent cell morphology pathway

and 9 (IC(50)

T-ALL cells treated with BMS-345541 displays nuclear translocation of FOXO3a and restoration of its functions

Xa generation) in a concentration dependent manner with IC50 of 0

176-fold more selective for class I HDACs

Moclobemide techin gallate SCH 51344-induced reversal of RAS-transformationMoclobemide is a reversible inhibitor of monoamine oxidase (RIMA) drug primarily used to treat depression and social anxiety. It is not approved for use in the United States, but is approved in other Western countries such as the UK and Australia. Due to the lack of anticholinergic, cardiovascular, cognitive and psychomotor impairments, moclobemide is advantageous in the elderly as well as those with cardiovascular disease. (https: en. wikipedia. org